Abstract
Mesenchymal stem cells (MSCs) are multipotent cells which are popular in human regenerative medicine. These cells can renew themselves and differentiate into several specialized cell types including osteoblasts, adipocytes, and chondrocytes under physiological and experimental conditions. MSCs can secret a lot of components including proteins and metabolites. These components have significant effects on their surrounding cells and also can be used to characterize them. This characterization of multipotent MSCs plays a critical role in their therapeutic potential. The metabolic profile of culture media verified by applying matrix-assisted laser desorption and ionization time-of-flight mass spectrometry (MALDI-TOF-MS) techniques. Also, the differentiation and development of MSCs have monitored through culture media metabolome or secretome (secreted metabolites). Totally, 24 potential metabolites were identified. Between them 12 metabolites are unique to BM-MSCs and 5 metabolites are unique to AD-MSCs. Trilineage differentiation including chondrocytes, osteoblasts, and adipocytes, as well as metabolites that are being differentiated, have been shown in different weeks. In the present study, the therapeutic effects of MSCs analyzed by decoding the metabolome for MSCs secretome via metabolic profiling using MALDI-TOF-MS techniques.
Similar content being viewed by others
Abbreviations
- MSCs:
-
Mesenchymal stem cells
- MALDI-TOF-MS:
-
Matrix-assisted laser desorption and ionization time-of-flight mass spectrometry
- PCA:
-
Principal component analysis
- ISCT:
-
International society for cell therapy
- HLA-DR:
-
Human leukocyte antigen—DR isotype
- CD:
-
Cluster of differentiation
- GVHD:
-
Graft versus host disease
- DHB:
-
Dihydroxybenzoic acid
- TFA:
-
Trifluoroacetic acid
- MATLAB:
-
Matrix laboratory
- hES cells:
-
Human embryonic stem cells
- MS:
-
Mass spectrometry
- METLIN:
-
Metabolite mass spectral database
- HMDB:
-
Human metabolome database
- KEGG:
-
Kyoto encyclopedia of genes and genomes
- PLS-DA:
-
Partial least squares discriminant analysis
- BM-MSCs:
-
Bone-marrow-derived mesenchymal stem cells
- AD-MSCs:
-
Adipose-derived mesenchymal stem cells
- m/z:
-
Mass-to-charge ratio
- AD:
-
Alzheimer's disease
References
Aghayan HR et al (2021) Mesenchymal stem cells’ seeded amniotic membrane as a tissue-engineered dressing for wound healing. Drug Deliv Transl Res. https://doi.org/10.1007/s13346-021-00952-3
Arjmand B et al (2019a) Different gene expression profile of mesenchymal stem cells from various sources. Genomics, proteomics, and metabolomics. Springer, pp 83–96
Arjmand B et al (2019b) Co-transplantation of human fetal mesenchymal and hematopoietic stem cells in type 1 diabetic mice model. Front Endocrinol (lausanne) 10:761
Bagher L et al (2015) Clinical grade human adipose tissue-derived mesenchymal stem cell banking. Acta Med Iran 53(9):540–546
Bianco P, Robey PG, Simmons PJ (2008) Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2(4):313–319
Brion C, Miller SG, Moore H (1992) Regulated and constitutive secretion. Differential effects of protein synthesis arrest on transport of glycosaminoglycan chains to the two secretory pathways. J Biol Chem 267(3):1477–1483
Brunstein CG, Setubal DC, Wagner JE (2007) Expanding the role of umbilical cord blood transplantation. Br J Haematol 137(1):20–35
Caplan AI, Dennis JE (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98(5):1076–1084
Caseiro AR et al (2019) Mesenchymal stem/stromal cells metabolomic and bioactive factors profiles: a comparative analysis on the umbilical cord and dental pulp derived Stem/Stromal Cells secretome. PLoS ONE. https://doi.org/10.1371/journal.pone.0221378
Cui L, Lu H, Lee YH (2018) Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases. Mass Spectrom Rev 37(6):772–792
Dominici M et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8(4):315–317
Dos Santos ÉC et al (2016) Noninvasive characterization of metabolites secreted in culture media by bovine embryos during in vitro production. Metabolomics 12(5):94
Fiehn O (2002) Metabolomics—the link between genotypes and phenotypes. Functional genomics. Springer, pp 155–171
Floegel A et al (2013) Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62(2):639–648
Friedenstein A et al (1968) Precursor cells for osteogenic and hemopoietic tissues. Analysis of heterotopic transplants of bone marrow. Tsitologia 10:557567
Friedenstein AJ et al (1974) Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues: cloning in vitro and retransplantation in vivo. Transplantation 17(4):331–340
Gilany K et al (2011) The profile of human sperm proteome. A Mini-REview J Reprod Infertil 12(3):193–199
Gilany K et al (2019) Metabolic profiling of the mesenchymal stem cells’ secretome. Genomics, proteomics, and metabolomics. Springer, pp 67–81
Goodacre R (2007) Metabolomics of a superorganism. J Nutr 137(1):259S-266S
Goodarzi P et al (2018) Mesenchymal stem cells-derived exosomes for wound regeneration. Cell biology and translational medicine, vol 4. Springer, pp 119–131
Griffin JL (2006) The cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball? Philos Trans R Soc B Biol Sci 361(1465):147–161
Han Y et al (2019) Mesenchymal stem cells for regenerative medicine. Cells 8(8):886
Hass R et al (2011) Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 9:12
Johnson CH, Gonzalez FJ (2012) Challenges and opportunities of metabolomics. J Cell Physiol 227(8):2975–2981
Johnson CH et al (2015) Bioinformatics: the next frontier of metabolomics. Anal Chem 87(1):147–156
Kilroy GE et al (2007) Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol 212(3):702–709
Kraly JR et al (2009) Microfluidic applications in metabolomics and metabolic profiling. Anal Chim Acta 653(1):23–35
Larijani B et al (2019) OMICs profiling of cancer cells. Genomics, proteomics, and metabolomics. Springer, pp 141–157
Lee MJ et al (2010) Proteomic analysis of tumor necrosis factor-α-induced secretome of human adipose tissue-derived mesenchymal stem cells. J Proteome Res 9(4):1754–1762
Minai-Tehrani A, Jafarzadeh N, Gilany K (2016) Metabolomics: a state-of-the-art technology for better understanding of male infertility. Andrologia 48(6):609–616
Orešič M et al (2011) Metabolome in progression to Alzheimer’s disease. Transl Psychiatry 1(12):e57–e57
Pan Z, Raftery D (2007) Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Anal Bioanal Chem 387(2):525–527
Phinney DG, Prockop DJ (2007) Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair–current views. Stem Cells 25(11):2896–2902
Price ST et al (2015) Sphingosine 1-phosphate receptor 2 regulates the migration, proliferation, and differentiation of mesenchymal stem cells. Int J Stem Cell Res Therapy 2(2):014
Sassoli C et al (2014) Mesenchymal stromal cell secreted sphingosine 1-phosphate (S1P) exerts a stimulatory effect on skeletal myoblast proliferation. PLoS ONE 9(9):e108662
Schiller J et al (2007) MALDI-TOF MS in lipidomics. Front Biosci 12:2568–2579
Shah SH et al (2012) Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease. Am Heart J 163(5):844-850.e1
Shyh-Chang N, Ng H-H (2017) The metabolic programming of stem cells. Genes Dev 31(4):336–346
Skalnikova HK (2013) Proteomic techniques for characterisation of mesenchymal stem cell secretome. Biochimie 95(12):2196–2211
Steuer AE, Brockbals L, Kraemer T (2019) Metabolomic strategies in biomarker research–new approach for indirect identification of drug consumption and sample manipulation in clinical and forensic toxicology? Front Chem 7:319
Teixeira FG, Salgado AJ (2020) Mesenchymal stem cells secretome: current trends and future challenges. Neural Regen Res 15(1):75
Ullah I, Subbarao RB, Rho GJ (2015) Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. https://doi.org/10.1042/BSR20150025
Ussher JR et al (2016) The emerging role of metabolomics in the diagnosis and prognosis of cardiovascular disease. J Am Coll Cardiol 68(25):2850–2870
Vizoso FJ et al (2017) Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine. Int J Mol Sci 18(9):1852
Wang TJ et al (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17(4):448
Wishart DS et al (2018) HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res 46(D1):D608–D617
Xia J, Wishart DS (2016) Using metabo analyst 3.0 for comprehensive metabolomics data analysis. Curr Protoc Bioinformatics 55:14.10.1-14.10.91
Yu L, Li K, Zhang X (2017) Next-generation metabolomics in lung cancer diagnosis, treatment and precision medicine: mini review. Oncotarget 8(70):115774
Zimmerlin L et al (2013) Mesenchymal stem cell secretome and regenerative therapy after cancer. Biochimie 95(12):2235–2245
Acknowledgements
The authors would like to acknowledge Dr. Mohsen Khorshidi and Shokouh Salimi for their kind support.
Author information
Authors and Affiliations
Contributions
KG supervised the study design, experiment, and manuscript writing. PG, MR participated in critical review of the manuscript. RK participated in the study design and interpretation. AT manuscript writing and participated in statistical data analysis. HA manuscript writing and participated in the study design. MM, AM performed statistical data analysis and analyzed the raw data and performed the metabolite identification. BL supervised the project from the scientific view of point and advised on experimental design. BA supervised and designed the experiment and manuscript writing and all authors reviewed the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Gilany, K., Goodarzi, P., Tayanloo-Beik, A. et al. Looking at time dependent differentiation of mesenchymal stem cells by culture media using MALDI-TOF-MS. Cell Tissue Bank 23, 653–668 (2022). https://doi.org/10.1007/s10561-021-09963-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10561-021-09963-3